Rs2304204

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.

No association between IRF3 polymorphism and susceptibility to hepatitis B virus infection in Chinese patients.